Skip to content

Fluoxetine for Obsessive-Compulsive Disorder

About Fluoxetine

What research says

No current published assessment exists for this exact Treatment and Need. This does not establish benefit or no benefit.

Published assessment

Not reviewed

No published assessment to inspect

The exact pair exists, but a research conclusion has not been published. Absence of a review is not evidence of benefit or no benefit.

Find care

Choose a place to see published offerings. A listing does not confirm current availability.

Choose a place Compare published Treatments for this Need

Why this Treatment appears for this Need

Why this Treatment appears in the Need landscape, separate from the research conclusion.

See relationship sourceDailyMed fluoxetine hydrochloride label · checked Oct 16, 2026

Relationship: labeled indication

This statement’s scope

Population

adults and pediatric patients 7 to 17 years of age with Obsessive Compulsive Disorder (OCD), as labeled

A supporting passage is not published here. Inspect the statement scope and linked source.

Published pointer: /sections/1

All published source details
Population

adults and pediatric patients 7 to 17 years of age with Obsessive Compulsive Disorder (OCD), as labeled

Formulation or format

tablets (product labeled Fluoxetine Hydrochloride capsule; Indications and Usage text refers to Fluoxetine Tablets; 60-mg scored tablet dosage form)

Indication

Obsessive Compulsive Disorder (OCD)

Section code

34067-9

Source collection coverage
country:US
Source pointer
/sections/1
Open published source in a new tab

See something wrong? Tell us. Your note is private. We check sources before we change this page.